Sullenger BA - Search Results

1

β-Cyclodextrin-containing polymer treatment of cutaneous lupus and influenza improves outcomes.

Kelly L, Olson LB, Rempel RE, Everitt JI, Levine D, Nair SK, Davis ME, Sullenger BA. Kelly L, et al. Among authors: sullenger ba. Mol Ther. 2022 Feb 2;30(2):845-854. doi: 10.1016/j.ymthe.2021.10.003. Epub 2021 Oct 8. Mol Ther. 2022. PMID: 34628051 Free PMC article.

2

Generation of species cross-reactive aptamers using "toggle" SELEX.

White R, Rusconi C, Scardino E, Wolberg A, Lawson J, Hoffman M, Sullenger B. White R, et al. Mol Ther. 2001 Dec;4(6):567-73. doi: 10.1006/mthe.2001.0495. Mol Ther. 2001. PMID: 11735341 Free article.

3

Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity.

Santulli-Marotto S, Nair SK, Rusconi C, Sullenger B, Gilboa E. Santulli-Marotto S, et al. Cancer Res. 2003 Nov 1;63(21):7483-9. Cancer Res. 2003. PMID: 14612549

4

Retargeting mobile group II introns to repair mutant genes.

Jones JP 3rd, Kierlin MN, Coon RG, Perutka J, Lambowitz AM, Sullenger BA. Jones JP 3rd, et al. Among authors: sullenger ba. Mol Ther. 2005 May;11(5):687-94. doi: 10.1016/j.ymthe.2005.01.014. Mol Ther. 2005. PMID: 15851007 Free article.

5

A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery.

Nimjee SM, Keys JR, Pitoc GA, Quick G, Rusconi CP, Sullenger BA. Nimjee SM, et al. Among authors: sullenger ba. Mol Ther. 2006 Sep;14(3):408-15. doi: 10.1016/j.ymthe.2006.04.006. Epub 2006 Jun 9. Mol Ther. 2006. PMID: 16765093 Free article.

6

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

McNamara JO 2nd, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E, Sullenger BA, Giangrande PH. McNamara JO 2nd, et al. Among authors: sullenger ba. Nat Biotechnol. 2006 Aug;24(8):1005-15. doi: 10.1038/nbt1223. Epub 2006 Jun 25. Nat Biotechnol. 2006. PMID: 16823371

7

Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses.

Lee J, Dollins CM, Boczkowski D, Sullenger BA, Nair S. Lee J, et al. Among authors: sullenger ba. Immunology. 2008 Oct;125(2):229-40. doi: 10.1111/j.1365-2567.2008.02833.x. Epub 2008 Apr 3. Immunology. 2008. PMID: 18393968 Free PMC article.

8

Aptamers in immunotherapy.

Dollins CM, Nair S, Sullenger BA. Dollins CM, et al. Among authors: sullenger ba. Hum Gene Ther. 2008 May;19(5):443-50. doi: 10.1089/hum.2008.045. Hum Gene Ther. 2008. PMID: 18473674 Free PMC article. Review. No abstract available.

9

Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.

Dollins CM, Nair S, Boczkowski D, Lee J, Layzer JM, Gilboa E, Sullenger BA. Dollins CM, et al. Among authors: sullenger ba. Chem Biol. 2008 Jul 21;15(7):675-82. doi: 10.1016/j.chembiol.2008.05.016. Chem Biol. 2008. PMID: 18635004 Free PMC article.

10

RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.

Mi Z, Guo H, Russell MB, Liu Y, Sullenger BA, Kuo PC. Mi Z, et al. Among authors: sullenger ba. Mol Ther. 2009 Jan;17(1):153-61. doi: 10.1038/mt.2008.235. Epub 2008 Nov 4. Mol Ther. 2009. PMID: 18985031 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters